Partners Group Acquires Majority Stake in FairJourney Biologics from GHO Capital

GHO Capital Invests in FairJourney Biologics

January 30, 2020

Biotechnology

London-based private equity firm GHO Capital has made an investment in FairJourney Biologics, a Porto-headquartered antibody discovery and biologics CRO, partnering with founders Antonio Parada and Maria Gonzalez-Pajuelo to accelerate global growth. The capital will support expansion of footprint, capacity and service capabilities through both organic and inorganic initiatives as FairJourney scales to meet rising demand from biopharma clients.

FairJourney Biologics Acquires Charles River Laboratories' South San Francisco Facility

March 3, 2025

Biotechnology

FairJourney Biologics S.A. has acquired Charles River Laboratories' South San Francisco site (formerly Distributed Bio), including facilities, staff, assets and proprietary antibody libraries and yeast display technology. The acquisition expands FairJourney's antibody discovery and engineering capabilities and establishes a strategic presence in a major U.S. biotech hub to better serve biopharma customers.

GHO Capital and Partners Group Invest in Sterling Pharma Solutions

May 25, 2023

Pharmaceuticals

GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.

GHO Capital Leads Consortium to Acquire Majority Stake in Envision Pharma Group from Ardian

November 5, 2020

Healthcare Services

GHO Capital Partners, leading a consortium that includes Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, together with Envision management and employees, has acquired a majority stake in Envision Pharma Group as Ardian exits its investment. The transaction will support Envision's continued growth, wider rollout of its iEnvision medical affairs platform and strategic acquisitions to expand its medical affairs, communications and technology capabilities.

GHO Capital Partners Acquires Scientist.com

November 20, 2025

Cloud & SaaS

GHO Capital Partners has completed the acquisition of Scientist.com, an AI-enabled R&D orchestration platform for the life sciences industry. The deal (terms undisclosed) will support Scientist.com's expansion of AI-driven capabilities and international growth while the company remains led by its existing management team in Solana Beach, California.

GHO Capital Recapitalizes ClearView Healthcare Partners

September 1, 2021

Healthcare Services

GHO Capital Partners LLP has acquired a majority ownership position in ClearView Healthcare Partners in a majority recapitalisation from RLH Equity Partners and ClearView management. The investment will support ClearView’s international expansion (particularly into Europe) and the broadening of its life-sciences consulting capabilities, including data analytics and pricing & market access services.